Focal lung infiltrate complicating PD-1 inhibitor use: A new pattern of drug-associated lung toxicity?
A 58-year-old woman with stage 4 adenocarcinoma of the lung being treated with pembrolizumab developed dyspnea, non-productive cough, and a right middle lobe infiltrate. Complete resolution of the infiltrate with cessation of pembrolizumab, initiation of prednisone and no antibiotic therapy suggeste...
Main Authors: | Sehgal, Sameep, Velcheti, Vamsidhar, Mukhopadhyay, Sanjay, Stoller, James K. |
---|---|
Format: | Online |
Language: | English |
Published: |
Elsevier
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026692/ |
Similar Items
-
Clinical significance of PD-L1 protein expression on tumor-associated macrophages in lung cancer
by: Schalper, Kurt Alex, et al.
Published: (2015) -
Marked Eosinophilia with Lung Infiltration
Published: (1943) -
High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas
by: Velcheti, Vamsidhar, et al.
Published: (2013) -
Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China
by: Si-Yang Liu, et al.
Published: (2017-07-01) -
Hereditary Amyloidosis with Recurrent Lung Infiltrates
by: Revelo, Alberto E., et al.
Published: (2016)